Cite
Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy
MLA
Susanta Kumar Rout, et al. “Mitochondrial Targeting Theranostic Nanomedicine and Molecular Biomarkers for Efficient Cancer Diagnosis and Therapy.” Biomedicine & Pharmacotherapy, vol. 153, no. 113451-, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.biopha.2022.113451.
APA
Susanta Kumar Rout, Vishnu Priya, Aseem Setia, Abhishesh Kumar Mehata, Syam Mohan, Mohammed Albratty, Asim Najmi, Abdulkarim M. Meraya, Hafiz A. Makeen, Murtaza M. Tambuwala, & Madaswamy S. Muthu. (2022). Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy. Biomedicine & Pharmacotherapy, 153(113451-). https://doi.org/10.1016/j.biopha.2022.113451
Chicago
Susanta Kumar Rout, Vishnu Priya, Aseem Setia, Abhishesh Kumar Mehata, Syam Mohan, Mohammed Albratty, Asim Najmi, et al. 2022. “Mitochondrial Targeting Theranostic Nanomedicine and Molecular Biomarkers for Efficient Cancer Diagnosis and Therapy.” Biomedicine & Pharmacotherapy 153 (113451-). doi:10.1016/j.biopha.2022.113451.